Advisory: Alerts on Qlife's agreement with global pharma company withdrawn
03/06/2026 09:00
ADVISORY-Alerts on Qlife's agreement with global pharma company withdrawn June 3 (Reuters) - Please ignore alerts on Qlife's evaluation agreement with a global pharmaceutical company. The chain repeats news published on June 1 and will be withdrawn. Please follow the link for Reuters coverage of the deal.
STORY_NUMBER:FWN42B08J
STORY_DATE:03/06/2026
STORY_TIME:[07:15:48]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million